The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Antioxidants for preventing pre-eclampsia
Open accessAbstract
Any antioxidants versus control or placebo, Outcome 1 Pre-eclampsia. . . . . . .Analysis 1.2.Comparison 1 Any antioxidants versus control or placebo, Outcome 2 Severe pre-eclampsia. . . . .Analysis 1.3.Comparison 1 Any antioxidants versus control or placebo, Outcome 3 Preterm birth. . . . . . .Analysis 1.4.Comparison 1 Any antioxidants versus control or placebo, Outcome 4 Small-for-gestational age. . . .Analysis 1.5.Comparison 1 Any antioxidants versus control or placebo, Outcome 5 Any baby death. . . . . . .Analysis 1.6.Comparison 1 Any antioxidants versus control or placebo, Outcome 6 Any baby death (subgrouped by timing of death). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.7.Comparison 1 Any antioxidants versus control or placebo, Outcome 7 Maternal death. . . . . . .Analysis 1.8.Comparison 1 Any antioxidants versus control or placebo, Outcome 8 Gestational hypertension. . .Analysis 1.9.Comparison 1 Any antioxidants versus control or placebo, Outcome 9 Severe hypertension. . . . .Analysis 1.10.Comparison 1 Any antioxidants versus control or placebo, Outcome 10 Use of antiypertensives. . .Analysis 1.11.Comparison 1 Any antioxidants versus control or placebo, Outcome 11 Elective delivery (induction of labour or elective caesarean section). . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.12.Comparison 1 Any antioxidants versus control or placebo, Outcome 12 Caesarean section (emergency plus elective). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.13.Comparison 1 Any antioxidants versus control or placebo, Outcome 13 Bleeding episodes (including placental abruption, APH, PPH, need for transfusion). . . . . . . . . . . . . . . . . . . .Analysis 1.14.Comparison 1 Any antioxidants versus control or placebo, Outcome 14 Serious maternal morbidity (including eclampsia, liver and renal failure, DIC, stroke). . . . . . . . . . . . . . . . . . .Analysis 1.15.Comparison 1 Any antioxidants versus control or placebo, Outcome 15 Gestational age at birth. . .Analysis 1.16.Comparison 1 Any antioxidants versus control or placebo, Outcome 16 Birthweight. . . . . . .Analysis 1.17.Comparison 1 Any antioxidants versus control or placebo, Outcome 17 Apgar score at 5 minutes. . .Analysis 1.18.Comparison 1 Any antioxidants versus control or placebo, Outcome 18 Respiratory distress syndrome.Analysis 1.19.Comparison 1 Any antioxidants versus control or placebo, Outcome 19 Chronic lung disease. . . .Analysis 1.20.Comparison 1 Any antioxidants versus control or placebo, Outcome 20 Neonatal bleeding episodes (intraventricular haemorrhage and periventricular leukomalacia). . . . . . . . . . . . . . . . .Analysis 1.21.Comparison 1 Any antioxidants versus control or placebo, Outcome 21 Necrotising enterocolitis. . .Analysis 1.22.Comparison 1 Any antioxidants versus control or placebo, Outcome 22 Retinopathy of prematurity. .Analysis 1.23.Comparison 1 Any antioxidants versus control or placebo, Outcome 23 Side-effects not sufficient to stop supplementation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.24.Comparison 1 Any antioxidants versus control or placebo, Outcome 24 Use of health service resources for the woman. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.25.Comparison 1 Any antioxidants versus control or placebo, Outcome 25 Length of stay in hospital -antenatal admission. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.26.Comparison 1 Any antioxidants versus control or placebo, Outcome 26 Use of health service resources for the infant. . . . . . . . . . . . . . . . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fetal nutrition and cardiovascular disease in adult life
Barker, D. J. P., Godfrey, K. M., Gluckman, P. D., Harding, J. E., Owens, J. A., & Robinson, J. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91224-a · Cited by 2,753
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance
Levine, M., Conry-Cantilena, C., Wang, Y., Welch, R. W., Washko, P. W., Dhariwal, K. R., Park, J. B., Lazarev, A., Graumlich, J. F., King, J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3704 · Cited by 1,325
A new recommended dietary allowance of vitamin C for healthy young women
Levine, M., Wang, Y., Padayatty, S. J., & Morrow, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171318198 · Cited by 496
Cited by
Gestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10803 · Cited by 2,089
The effects of oxidative stress on female reproduction: a review
Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., & Gupta, S. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-49 · Cited by 1,637
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Pre-eclampsia: pathophysiology and clinical implications
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019) · BMJ · doi:10.1136/bmj.l2381 · Cited by 1,250
Metadata
- Authors
- Rumbold, A., Duley, L., Crowther, C. A., & Haslam, R. R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2008-01-23
- Volume
- 2012
- Issue
- 6
- Pages
- CD004227-CD004227
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1788301041
- Cited by
- 306
- References
- 5
- FWCI
- 32.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antioxidants for preventing pre-eclampsia. https://app.cochat.ai/papers/10.1002/14651858.cd004227.pub3
- The paper
- Rumbold, A., Duley, L., Crowther, C. A., & Haslam, R. R. (2008). Antioxidants for preventing pre-eclampsia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004227.pub3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
